Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

unknown125%
completed250%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
completedphase_1

Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19

NCT04824443
recruitingnot_applicable

Interventions Against Fatigue in Patients With Myasthenia Gravis

NCT06659627
completednot_applicable

Exercise and Vagus Nerve Stimulation in IBS

NCT06769516
unknownnot_applicable

Validation of Oxygen Uptake Efficiency Slope in Patients With Stroke

NCT03960918

Clinical Trials (4)

Showing 4 of 4 trials
NCT04824443Phase 1

Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19

Completed
NCT06659627Not Applicable

Interventions Against Fatigue in Patients With Myasthenia Gravis

Recruiting
NCT06769516Not Applicable

Exercise and Vagus Nerve Stimulation in IBS

Completed
NCT03960918Not Applicable

Validation of Oxygen Uptake Efficiency Slope in Patients With Stroke

Unknown

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4